USFDA10 Mar 2026, 05:31 pm
Godavari Biorefineries' Japanese Patent for Antiviral Therapeutics Granted
AI Summary
Godavari Biorefineries Ltd. has announced that its Japanese patent application titled 'Use of Compounds for Treating Viral Infections' (No. 2022-568620) has been granted by the Japan Patent Office. The patent covers the use of compounds for inhibiting V-ATPase activity in a cell and methods for treating viral infections using these compounds. This grant strengthens the company's intellectual property protection in Japan and adds value to its portfolio in the antiviral therapeutics sector.
Key Highlights
- Godavari Biorefineries' Japanese patent application No. 2022-568620 titled 'Use of Compounds for Treating Viral Infections' has been granted.
- The patent covers the use of compounds for inhibiting V-ATPase activity in a cell and methods for treating viral infections using these compounds.
- This grant strengthens the company's intellectual property protection in Japan.
- The patent adds value to the company's portfolio in the antiviral therapeutics sector.
- The invention is a significant step forward in the antiviral therapeutics sector.
Price Impact
More from GODAVARIB